These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7501469)

  • 21. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
    Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA; Mullen CA; Morgan RA
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency expression of integrated proviruses derived from enhancer trap retroviruses.
    Sablitzky F; Jönsson JI; Cohen BL; Phillips RA
    Cell Growth Differ; 1993 Jun; 4(6):451-9. PubMed ID: 8373730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forced integration of Moloney murine leukemia virus DNA with a mutant integration site occurs through recombination with VL30 DNA.
    Murphy JE; Goff SP
    Virology; 1994 Oct; 204(1):458-61. PubMed ID: 8091679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-deleting retrovirus vectors for gene therapy.
    Russ AP; Friedel C; Grez M; von Melchner H
    J Virol; 1996 Aug; 70(8):4927-32. PubMed ID: 8763996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression from transcriptionally disabled retroviral vectors.
    Yee JK; Moores JC; Jolly DJ; Wolff JA; Respess JG; Friedmann T
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5197-201. PubMed ID: 3474647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
    Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
    Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transduction of cellular neo mRNA by retrovirus-mediated recombination.
    Stuhlmann H; Dieckmann M; Berg P
    J Virol; 1990 Dec; 64(12):5783-96. PubMed ID: 1700824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
    Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS
    J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the use of double FLP recognition targets (FRTs) in the LTR of retroviruses for the construction of high producer cell lines.
    Karreman S; Hauser H; Karreman C
    Nucleic Acids Res; 1996 May; 24(9):1616-24. PubMed ID: 8649977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved self-inactivating retroviral vectors derived from spleen necrosis virus.
    Olson P; Nelson S; Dornburg R
    J Virol; 1994 Nov; 68(11):7060-6. PubMed ID: 7933088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock induced excision of selectable marker genes in transgenic banana by the Cre-lox site-specific recombination system.
    Chong-Pérez B; Kosky RG; Reyes M; Rojas L; Ocaña B; Tejeda M; Pérez B; Angenon G
    J Biotechnol; 2012 Jun; 159(4):265-73. PubMed ID: 21839123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of 3' non-coding sequences for efficient retrovirus-mediated gene transfer in avian cells revealed by self-inactivating vectors.
    Flamant F; Aubert D; Legrand C; Cosset FL; Samarut J
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():39-46. PubMed ID: 8380836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
    Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retargeting of retroviral integration sites for the predictable expression of transgenes and the analysis of cis-acting sequences.
    Schübeler D; Maass K; Bode J
    Biochemistry; 1998 Aug; 37(34):11907-14. PubMed ID: 9718314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.
    Daniel R; Smith JA
    Hum Gene Ther; 2008 Jun; 19(6):557-68. PubMed ID: 18533894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of retroviral vectors.
    Gabriel R; Schmidt M; von Kalle C
    Curr Opin Immunol; 2012 Oct; 24(5):592-7. PubMed ID: 22981243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved gene expression by a U3-based retroviral vector.
    Chen BF; Hsieh CL; Chen DS; Hwang LH
    Biochem Biophys Res Commun; 1992 Apr; 184(1):330-7. PubMed ID: 1567440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that a major class of mouse endogenous long terminal repeats (LTRs) resulted from recombination between exogenous retroviral LTRs and similar LTR-like elements (LTR-IS).
    Schmidt M; Glöggler K; Wirth T; Horak I
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6696-700. PubMed ID: 6093113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.